Biocon arm gets market authorisation in EU for two biosimilars of Denosumab

As per clinical data, both Denosumab biosimilars have comparable quality, safety and efficacy to the reference product, the company said.

As per clinical data, both Denosumab biosimilars have comparable quality, safety and efficacy to the reference product, the company said.

On Wednesday (July 2), the rupee depreciated 3 paise to close at 85.62 against US dollar.

Abneesh Roy of Nuvama Institutional Equities sees better prospects in food-focused companies like Britannia and Nestle India, given faster expected growth in those categories.

Alembic Pharmaceuticals aims to commercialise Utility’s FDA-approved and pipeline products in the US market.

On Thursday, market tech analyst Mitessh Thakkar recommended these stocks for the short term.

Brokerage firm Citi mentioned that steel prices could come under further pressure due to ongoing demand-supply dynamics.

Macquarie believes current margin pressures are temporary and expects banks to deliver a solid 15% EPS CAGR over the next three years.

The lender’s total deposits for the first quarter increased 20% to ₹35,990 crore in comparison to ₹29,920 crore in the year-ago period.

Sensex Today | Stock Market LIVE Updates: Apart from the weekly options expiry, the market will also have to react to a trade deal signed between the US and Vietnam overnight, which puts India’s apparel stocks like Gokaldas Exports, among…

Treasuries edged up modestly in early Asian trading on Thursday after yields rose in the prior session following heavy selling in the UK, where concerns about Chancellor of the Exchequer Rachel Reeves’ future reignited questions over the nation’s fiscal position.…